Table Of Content

Maturitas, 16 (1993) 219 Elsevier Scientific Publishers Ireland Ltd. Author Index Volume 16 Akhtar, Y. 61 Jimeno, N.P., 39 Pors Nielsen, S., 13 Alos, L. 139 Jondet, M., 185 Poudes, G., 39 Arko, H. 123 Juste, G., 139 Pryse-Davies, J., 23 Puche, R.C., 39 Badaruddin, N. 61 Kangas, I., 163 Barry-Kinsella, C. 71 Khan, S., 61 Rainio, J., 123 Bennett, P. 13 Koninckx, P.R., 97 Roberti, A., 39 Birkhaeuser, M.H. 111 Kgster, A., 49 Robinson, S.C., 61 Bocanera, R. 39 Roger, M., 185 Roveri, E., 39 Laine, H., 123 Castelo-Branco, C., 133 Cornillie, F.J., 97 Lauweryns, J.M., 97 Saure, A., 1 Costantini, C., 31 Lahteenmaki, P., 123 Schenkel, L., 23 Leone, M., 31 Short, M., 71 de Cecco, L., 31 Leone, M.M., 31 Sipinen, S., 123 Lindskog, M., 145 Dehennin, L., 185 Smith, P., 145 Lopez, C.C., 139 Suhonen, S., 123 Fraser, D., 23 Svenstrup, B., 13 MacLennan, A., 175 Gallo, G., 31 MacLennan, A.H., 175 Tikkanen, M.J., | Garde, K., 49 Malin, M., 163 Topo, P., 163 Gonzalez-Merlo, J., 133 Martinez-Hernandez, H., 139 Tozzini, R., 39 Gydesen, H., 13 Massajoli, M., 31 Micic, S., 13 Ulmsten, U., 145 Haenggi, W., 111 Milner, M., 71 Harrison, R.F., 71 Munk-Jensen, N., 13 Viinikka, L., 1 Heimer, G., 145 Voci, A., 31 Hemminki, E., 163 Nahoul, K., 185 Henrik-Nielsen, R., 13 Wasti, S.C., 61 Hirvonen, E., 1 Whitehead, M., 23 Obel, E.B., 13 Wilbush, J., 157 Ibanez, F., 139 Wilson, D., 175 Pérez-Lopez, F.R., 139 Jensen, B.M., 13 Pons, F., 133 Ylikorkala, O., 1 Maturitas, 16 (1993) 221-222 Elsevier Scientific Publishers Ireland Ltd. Subject Index Volume 15 Age, menopause, socioeconomic, Pakistan, Endometrium, cyproterone acetate, hormone re- symptoms, developing countries, 61 placement, 97 Aging, growth factors, endometrium, 31 Endometrium, growth factors, aging, 31 Australia, oestrogen, menopause, prevalence, Endometrium, oestradiol, norethisterone acetate, 175 climacteric symptoms, hormone replacement therapy, metabolism, 13 Biorhythm, climacteric research/biology, uno- Endometrium, transdermal, oestradiol, progesto- vular menstruation, progestogens, repeated gen, 23 pregnancies, cancer of the breast, 157 Estradiol, pharmacokinetics, progesterone, es- Bone density, menopause, oestrogen, progesto- trone, deoxycorticosterone, pregnenolone, gen, lipoproteins, | sulfates, 185 Bone mass, dual photon absorptiometry, hor- Estrogens, menopause, postmenopause, prescrib- mone relpacement therapy, 133 ing, hormone therapy, progestins, 163 Estrone, pharmacokinetics, progesterone, estra- Calcium supplementation, hypercalciuria, cit- diol, deoxycorticosterone, pregnenolone, rate, oxalate, oestrogen replacement therapy, sulfates, 185 urinary saturation, 39 Cancer of the breast, climacteric research/ General population, sexual desire, menopause, biology, unovular menstruation, progestogens, longitudinal analysis, 49 biorhythm, repeated pregnancies, 157 Growth factors, endometrium, aging, 31 Cardiovascular risk, hormone replacement therapy, lipids, medrogestone, conjugated estrogens, 111 Hormone relpacement therapy, bone mass, dual Citrate, hypercalciuria, oxalate, oestrogen re- photon absorptiometry, 133 placement therapy, calcium supplementation, Hormone replacement therapy, cardiovascular urinary saturation, 39 risk, lipids, medrogestone, conjugated estro- Climacteric research/biology, unovular menstru- gens, 111 ation, progestogens, biorhythm, repeated preg- Hormone replacement therapy, oestradiol, nancies, cancer of the breast, 157 norethisterone acetate, climacteric symptoms, endometrium, metabolism, 13 Climacteric symptoms, oestradiol, norethisterone Hormone replacement, endometrium, cypro- acetate, hormone replacement therapy, endometrium, metabolism, 13 terone acetate, 97 Climacteric, menopause, menopause clinic, 71 Hormone therapy, menopause, postmenopause, Conjugated estrogens, hormone replacement prescribing, estrogens, progestins, 163 therapy, cardiovascular risk, lipids, medro- Hypercalciuria, citrate, oxalate, oestrogen replacement therapy, calcium supplementation, gestone, 111 Cyproterone acetate, endometrium, hormone re- urinary saturation, 39 placement, 97 Intravaginal ring, urogenital atrophy, oestradiol, Deoxycorticosterone, pharmacokinetics, pro- 145 Lipids, hormone replacement therapy, car- gesterone, estradiol, estrone, pregnenolone, diovascular risk, medrogestone, conjugated es- sulfates, 185 trogens, 111 Developing countries, menopause, socioecon- Lipoproteins, menopause, oestrogen, progesto- omic, Pakistan, age, symptoms, 61 gen, bone density, | Dual photon absorptiometry, bone mass, hor- Longitudinal analysis, sexual desire, menopause, mone relpacement therapy, 133 general population, 49 222 Medrogestone, hormone replacement therapy, ceptors, vagina, menstrual cycle, postmeno- cardiovascular risk, lipids, conjugated estro- pause, 139 gens, 111 Pregnenolone, pharmacokinetics, progesterone, Menopause clinic, menopause, climacteric, 71 estradiol, estrone, deoxycorticosterone, Menopause, menopause clinic, climacteric, 71 sulfates, 185 Menopause, oestrogen, prevalence, Australia, Prescribing, menopause, postmenopause, hor- 175 mone therapy, estrogens, progestins, 163 Menopause, oestrogen, progestogen, lipopro- Prevalence, oestrogen, menopause, Australia, teins, bone density, 1 175 Menopause, postmenopause, prescribing, hor- Progesterone receptors, oestrogen receptors, mone therapy, estrogens, progestins, 163 vagina, menstrual cycle, pregnancy, postmeno- Menopause, sexual desire, general population, pause, 139 longitudinal analysis, 49 Progesterone, pharmacokinetics, estradiol, es- Menopause, socioeconomic, Pakistan, age, trone, deoxycorticosterone, pregnenolone, symptoms, developing countries, 61 sulfates, 185 Menstrual cycle, oestrogen receptors, pro- Progestins, menopause, postmenopause, pre- gesterone receptors, vagina, pregnancy, scribing, hormone therapy, estrogens, 163 postmenopause, 139 Progestogen, menopause, oestrogen, lipopro- Metabolism, oestradiol, norethisterone acetate, teins, bone density, | climacteric symptoms, hormone replacement Progestogen, transdermal, oestradiol, endomet- therapy, endometrium, 13 rium, 23 Progestogens, climacteric _research/biology, Norethisterone acetate, oestradiol, climacteric unovular menstruation, biorhythm, repeated symptoms, hormone replacement therapy, pregnancies, cancer of the Breast, 157 endometrium, metabolism, 13 Oestradiol, norethisterone acetate, climacteric Repeated pregnancies, climacteric research/bio- symptoms, hormone replacement therapy, logy, unovular menstruation, progestogens, endometrium, metabolism, 13 biorhythm, cancer of the breast, 157 Oestradiol, transdermal, progestogen, endometrium, 23 Sexual desire, menopause, general population, Oestradiol, urogenital atrophy, intravaginal ring, longitudinal analysis, 49 145 Silastic, oestrogen replacement therapy, subcu- Oestrogen receptors, progesterone receptors, taneous implant, 123 vagina, menstrual cycle, pregnancy, postmeno- Socioeconomic, menopause, Pakistan, age, pause, 139 symptoms, developing countries, 61 Oestrogen replacement therapy, hypercalciuria, Subcutaneous implant, oestrogen replacement citrate, oxalate, calcium supplementation, therapy, silastic, 123 urinary saturation, 39 Sulfates, pharmacokinetics, progesterone, estra- Oestrogen replacement therapy, subcutaneous diol, estrone, deoxycorticosterone, pregneno- implant, silastic, 123 lone, 185 Oestrogen, menopause, prevalence, Australia, Symptoms, menopause, socioeconomic, Pak- 175 istan, age, developing countries, 61 Oestrogen, menopause, progestogen, lipoproteins, bone density, 1 Oxalate, hypercalciuria, Transdermal, oestradiol, progestogen, endometrium, 23 citrate, oestrogen replacement therapy, calcium supplementation, urinary saturation, 39 Unovular menstruation, climacteric research/bio- Pakistan, menopause, socioeconomic, age, symp- logy, progestogens, biorhythm, repeated preg- toms, developing countries, 61 nancies, cancer of the breast, 157 Pharmacokinetics, progesterone, estradiol, es- Urinary saturation, hypercalciuria, citrate, ox- trone, deoxycorticosterone, pregnenolone, alate, oestrogen replacement therapy, calcium sulfates, 185 supplementation, 39 Postmenopause, menopause, prescribing, hor- Urogenital atrophy, oestradiol, intravaginal ring, mone therapy, estrogens, progestins, 163 145 Postmenopause, oestrogen receptors, progesterone receptors, vagina, menstrual cycle, Vagina, oestrogen receptors, progesterone recep- pregnancy, 139 tors, menstrual cycle, pregnancy, postmeno- Pregnancy, oestrogen receptors, progesterone re- pause, 139